Global Prostate Health Market Trends and Growth Analysis 2025–2029

Global Prostate Health Market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Prostate Health Market Expected To Expand Between 2025 And 2029?

The prostate health market has experienced substantial expansion in recent years. Forecasts indicate it will expand from $34.07 billion in 2024 to $37.23 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 9.3%. Historically, this growth has been influenced by an aging population, increased PSA screening, rising awareness campaigns, advancements in hormone therapy, and growing incidence rates.

The prostate health market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $52.81 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.1%. This projected growth over the forecast period stems from the increasing integration of precision medicine, broader utilization of AI-driven diagnostic tools, the proliferation of targeted radiotherapies, a heightened demand for minimally invasive treatment options, and enhanced genetic profiling for risk assessment. Key developments expected during this period involve AI-powered risk assessment methodologies, progress in liquid biopsy techniques, the evolution of next-generation radiotheranostics, novel immunotherapy approaches, and continuous real-time biomarker monitoring.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21265&type=smp

What Are The Main Drivers Boosting The Prostate Health Industry’s Expansion?

The increasing incidence of prostate cancer is projected to fuel the expansion of the prostate health market moving forward. Prostate cancer is a malignancy that develops when cells within the prostate gland proliferate uncontrollably, frequently appearing as adenocarcinomas, which represent the most common type of this illness in men. The escalating prevalence of prostate cancer is primarily attributable to the growing elderly population, increased screening efforts, and lifestyle aspects such as obesity and physical inactivity. Maintaining prostate health is vital for the prevention, early detection, and proper management of prostate cancer. For example, in January 2023, the American Cancer Society (ACS), a US-based non-profit organization, indicated that approximately 288,300 new prostate cancer cases were anticipated to be diagnosed in the U.S. during 2023, with an estimated 34,700 fatalities resulting from the condition. Therefore, the rising prevalence of prostate cancer will be a driving force for the growth of the prostate health market.

What Are The Leading Segments Analyzed In The Prostate Health Market?

The prostate healthmarket covered in this report is segmented –

1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis

2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments

3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels

Subsegments:

1) By Prostate Cancer: Localized Prostate Cancer; Metastatic Prostate Cancer

2) By Benign Prostate Hyperplasia: Mild BPH; Moderate BPH; Severe BPH

3) By Prostatitis: Acute Bacterial Prostatitis; Chronic Bacterial Prostatitis; Chronic Prostatitis (Non-Bacterial)

Which Competitive Trends Are Defining The Prostate Health Market Structure?

Leading firms within the prostate health sector are prioritizing technological innovations, particularly AI-driven risk assessment, to achieve a competitive advantage. This AI-powered risk assessment employs artificial intelligence algorithms to scrutinize data and forecast potential hazards, thereby facilitating well-informed choices and enhancing results. As an example, in September 2024, Nanostics Inc., a Canada-based clinical-stage biotechnology company, collaborated with Protean BioDiagnostics, a US-based biotechnology company, to introduce CDX Prostate, a diagnostic instrument designed for men susceptible to aggressive prostate cancer. The tool leverages biological data, clinical information, and AI-driven learning models to calculate a risk score for aggressive prostate cancer. CDX Prostate incorporates sophisticated machine learning algorithms to evaluate diverse biological and clinical data, offering a more precise risk score for aggressive prostate cancer than conventional approaches. This test assists healthcare professionals and individuals in making well-considered decisions regarding whether to undergo a biopsy subsequent to an elevated prostate-specific antigen (PSA) test outcome or an unusual digital rectal exam (DRE).

Which Key Players Are Driving Competition In The Prostate Health Market?

Major companies operating in the prostate health market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Bayer AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Genentech Inc., Teleflex Inc., Elekta AB, Myriad Genetics Inc., Freenome, Theragenics Corporation, CureVac BV, ArsenalBio, Roivant Sciences, Artera Inc., Veru Inc., HistoSonics Inc., Immunic Inc., Ezra, Francis Medical, CorTechs Labs, Lucida Medical, Serimmune Inc., Alessa Therapeutics.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/prostate-health-global-market-report

How Do Regional Market Performances Compare Within The Prostate Health Industry?

North America was the largest region in the prostate health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Prostate Health Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21265&type=smp

Browse Through More Reports Similar to the Global Prostate Health Market 2025, By The Business Research Company

Healthcare Ecommerce Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-ecommerce-global-market-report

Other Health And Personal Care Stores Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/other-health-and-personal-care-stores-global-market-report

Residential Substance Abuse And Mental Health Facilities Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/residential-substance-abuse-and-mental-health-facilities-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model